Gambro Pty Limited v Fresenius Medical Care South-East Asia Pty Ltd [2000] FCA 1044
Leave to appeal was refused because the proposed appeal would have no prospect of success. The specification as filed sufficiently and reasonably clearly disclosed systems for preparing dialysis or replacement fluids and component fluids, a fluid for a medical procedure included component fluids, the contextual substitution of fluid for water in claim 4 did not broaden the claim, deletion of delivery words removed surplusage without broadening the claim, and new claim 88 was in substance disclosed because the specification taught production of a substantially saturated solution by water passing downward through the powder column without requiring measuring or flow-regulating means.
- Jurisdiction
- Australia
- Judgment Date
- 04 August 2000
- Procedural Posture
- Patent Infringement Proceeding With Cross Claim for Revocation and Application to Amend Patent Claims / Application for Leave to Appeal From Interlocutory Order Directing Amendments to Patent Specification
- Outcome
- Application for leave to appeal dismissed.
- Legal Topics
- ['amendment of Patent Specification' 'allowability of Amendments' 'fair Basis and Substantial Disclosure' 'leave to Appeal From Interlocutory Judgment' 'costs']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Patent Infringement Proceeding With Cross Claim for Revocation and Application to Amend Patent Claims / Application for Leave to Appeal From Interlocutory Order Directing Amendments to Patent Specification
Legal Issues
- 1 ["Whether leave should be granted to appeal Tamberlin J's interlocutory order allowing amendments to Australian patent no 595423." 'Whether the proposed amended claims would claim matter not in substance disclosed in the specification as filed or would not in substance fall within the scope of the claims before amendment under s 102 of the Patents Act 1990 (Cth).' 'Whether the amended claims would fail to comply with s 40(2) or (3) of the Patents Act 1990 (Cth) because they did not define the invention, were not clear and succinct, or were not fairly based on the matter described in the specification.' 'Whether references to a dialysis or replacement fluid or a component fluid thereof, the substitution of fluid for water, deletion of alleged surplusage, and new claim 88 impermissibly broadened or altered the claims.']
Ratio Decidendi
Leave to appeal was refused because the proposed appeal would have no prospect of success. The specification as filed sufficiently and reasonably clearly disclosed systems for preparing dialysis or replacement fluids and component fluids, a fluid for a medical procedure included component fluids, the contextual substitution of fluid for water in claim 4 did not broaden the claim, deletion of delivery words removed surplusage without broadening the claim, and new claim 88 was in substance disclosed because the specification taught production of a substantially saturated solution by water passing downward through the powder column without requiring measuring or flow-regulating means.
Court Disposition
Application for leave to appeal dismissed.
Orders
- ['The application for leave to appeal is dismissed.' 'The respondent Fresenius Medical Care South East Asia Pty Limited pay the costs of the applicants Gambro Pty Limited and Gambro AB to be taxed.']
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment